This FTiH-PoC study aims to provide an early evaluation of the efficacy of the investigational vaccine as there are no established immunogenicity correlates of protection against infections caused by Neisseria gonorrhoeae.

• Safety and efficacy of GSK Neisseria gonorrhoeae GMMA (NgG) investigational vaccine when administered to healthy adults 18 to 50 years of ag … Ended
  2022-500883-37-00 7 2023-10-02

Showing 1–1 of 1 trials